Furthermore, upregulation of SR-BI was found to be associated with greater tumor progression and a poor prognosis in breast carcinoma, whereas in vitro SR-BI knockdown studies showed a reduction in Akt activation, thereby hindering breast cancer aggression and metastasis. This evidence concerns the gene SCARB1 and breast carcinoma.